Product Images Wilate - Von Willebrand Factor/coagulation Factor Viii Complex (human)
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 15 images provide visual information about the product associated with Wilate - Von Willebrand Factor/coagulation Factor Viii Complex (human) NDC 68982-182 by Octapharma Usa Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Image File - img0001
This text provides a formula for calculating the required IU (international units) of a medication based on body weight and desired VWFRCo (von Willebrand Factor Ristocetin Cofactor) rise, as well as the expected VWE-RCo (von Willebrand Factor Ristocetin Cofactor activity) rise. The equation also includes conversion factors between IU, body weight per IU/dL, and expected rise percentage.*
Image File - img0002
Image File - img0003
The text describes a formula for calculating the required IU of Factor VIIT rise based on body weight (in kg) and desired percentage increase, as well as the expected percentage rise in Factor VIIT levels based on the administered IU and body weight.*
Image File - img0004
Image File - img0005
Image File - img0006
Image File - img0007
Image File - img0008
This text provides information on the Virus Reduction Factor for enveloped and non-enveloped viruses, along with the production steps that were applied to test viruses including HIV-1, SBV, BVDV, REO3, HAV, and PPV. The text also mentions different treatments with their respective percentage reduction values for viruses. The Global Reduction Factor values are also given for the utilized treatments.*
Image File - img0009
This appears to be a table showing data related to initial and subsequent doses of subjects across different locations. The first column is for all subjects with a total count of 45 while the second column is restricted to subjects aged between 5 to 16 years, with a count of 11. The subsequent columns show the location/type of infusion, the number of doses administered, the average dose size (mean) plus the standard deviation (SD), and the range of infusions. The last row shows data related to the Otice location, specifying the count of subjects, average dose size, and range of infusions.*
Image File - img0010
Image File - img0011
Image File - img0012
Image File - img0013
Image File - img0014
Product Name: wilate® Purpose: Used for Intravenous injection only Ingredients: von Willebrand Factor/Coagulation Factor VIII Complex (Human), Solvent Detergent and Heat Treated Dosage: 500 IU Preparation: Powder for intravenous injection upon reconstitution with supplied diluent Note: The additional text is not-readable and non-English characters.*
img0015
Description: von Willebrand Factor and Coagulation Factor VII Complex (Human) are combined in a medication called Wilate, which is available in a powder form for intravenous injection. This medication is for prescription use only and should only be administered after being reconstituted with the provided diluent. It has a total protein content of up to 15.0 and is treated with solvent detergent and heat.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.